Skip to Main content Skip to Navigation

Processus de choix de projets dans l'industrie pharmaceutique et politique de santé.

Abstract : On the one hand, drug is a private good that is designed, developed and commercialized by an industry: the pharmaceutical industry. On the other hand, it has some characteristics of a public good because of its purpose: health. The aim of this thesis is to analyze the two dimensions of drug in order to deduce some public incentives that could reinforce the public dimension such as public health in the decision-making process of the private firms (externalities). First, we analyze the available tools used by public authorities that may have a direct or indirect role in inciting firms to innovate: intellectual property right, public research policy, Research and Development tax credit and some other different tools used to regulate the commercialization of drugs (mainly used in Europe). We show that public authorities do not play any direct role in the decision-making process of the firms. Secondly, we analyze the decision-making process of the pharmaceutical Research and Development strategy. Research and Development programs are highly risky and this is even more the case for innovating products. According to the strategy of a firm, Research and Development projects are competing each other for the internal resources, implying portfolio management. The least innovating projects act as securing the whole Research and Dévelopment portfolio. Third, we deduce from this two parts some theoretical public incentives in order to favor innovation in the specific context of drug. Then, we propose a model of the portfolio decision-making process, allowing us to simulate the potential impact of our theoretical public incentives. We show that a public participation in Research and Development costs, a public policy based on prices and/or on intellectual property rights could have a significant and positive effect on the decision-making-process of pharmaceutical firms.
Document type :
Complete list of metadata
Contributor : Ecole Polytechnique Connect in order to contact the contributor
Submitted on : Wednesday, July 21, 2010 - 10:23:47 AM
Last modification on : Tuesday, April 19, 2022 - 10:12:10 AM
Long-term archiving on: : Friday, October 22, 2010 - 3:07:50 PM


  • HAL Id : pastel-00000734, version 1



Cécile Hourcade-Behaghel. Processus de choix de projets dans l'industrie pharmaceutique et politique de santé.. Sciences de l'Homme et Société. Ecole Polytechnique X, 2003. Français. ⟨pastel-00000734⟩



Record views


Files downloads